A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I ...

ITV Chaser Mark Labbett has received supportive messages from fans after issuing a health update. The quizzer, 59, has lost a ...

The Oura Ring 4 set a standard in the smart ring industry, and its CEO is excited for the future to make Oura the ring ...

Stocks tend to perform well in January, but that's not a good reason to invest this month. Strong returns aren't made in a ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

Dexcom's shares had fallen nearly 37% last year ... launched device Stelo for adults aged 18 and older who do not use insulin, making it the first continuous glucose monitor available for over ...

Over the last four years, health systems across the United States have phased out the use of several clinical tools that use race to predict patient outcomes, replacing them with race-free ...

The company designs, develops and focuses on commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes. Its products include DexCom G4 PLATINUM ...

In August, DexCom announced the availability of Stelo, the first over-the-counter CGM biosensor in the United States for people with type II diabetes who do not use insulin. The expansion in the ...

Dexcom (Nasdaq:DXCM) today announced preliminary financial results with projections for significant sales growth in 2025. Shares of DXCM dipped 1.5% to $76.57 in mid-morning trading today. The San ...